An observational study in Aging, Epigenetic Aging and Infertility, sponsored by IVI Murcia. Recruiting at 1 site in Spain. Open to male participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-10.
Sponsored by IVI Murcia · Observational
This observational study will evaluate whether sperm cryopreservation can help preserve sperm quality and molecular characteristics that may be affected by increasing paternal age. Men aged 18 years and older will provide a semen sample and a blood sample for laboratory analysis. Each semen sample will be divided into fresh, slow-frozen, and vitrified aliquots. The study will compare sperm quality (as assessed by computer-assisted sperm analysis), DNA methylation profiles, DNA fragmentation, sperm telomere length before and after cryopreservation. The effects of age on these parameters will also be assessed. The impact of age on seminal plasma extracellular vesicle composition and blood cell telomere length will also be analysed. The goal is to determine whether sperm cryopreservation may represent a strategy for preserving sperm characteristics associated with younger paternal age.
The aging process is associated with declining fertility and increased risks of adverse reproductive and offspring health outcomes. Although the effects of maternal age have been extensively studied, the impact of paternal aging on sperm quality, reproductive outcomes, and molecular characteristics of sperm remains incompletely understood.
The primary objective of this study is to evaluate whether sperm cryopreservation may serve as an alternative to the use of sperm collected at older ages in assisted reproduction treatments. The primary endpoint is the difference in sperm DNA methylation patterns between fresh ejaculated samples and samples subjected to cryopreservation. Cryopreservation will be considered a potentially valid strategy if DNA methylation patterns remain substantially preserved following the cryopreservation process.
At least 45 male participants will be recruited and grouped according to age. Participants will provide one semen sample and a peripheral blood sample. Following routine semen analysis, each semen sample will be divided into three aliquots: fresh, slow-frozen, and vitrified. Cryopreserved aliquots will be stored in liquid nitrogen and subsequently thawed or warmed for analysis.
Standard semen parameters, including volume, concentration, motility, sperm kinetics, and morphology, will be evaluated. Additional analyses will include sperm DNA methylation, DNA fragmentation, telomere length, and characterization of extracellular vesicles and their composition. Identical assessments will be performed on fresh and cryopreserved samples to compare the effects of slow freezing and vitrification.
Secondary objectives include evaluating age-related differences in semen quality and molecular biomarkers, identifying markers associated with biological gamete age, characterizing age-related differences in seminal extracellular vesicles, and exploring associations between sperm molecular characteristics and lifestyle. Participants will also complete validated questionnaires regarding lifestyle and dietary habits.
2,085 studies on the registry are indexed under Infertility; 357 are open to participants now.
This study's planned enrollment of 45 is below the median of 200 across 592 observational studies indexed under Infertility.
Browse Infertility studies →IVI Murcia is the lead sponsor of 3 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Adult men aged 18-65 years attending IVI Murcia for semen analysis, fertility assessment, semen donation, or assisted reproduction treatment who meet the study eligibility criteria and provide informed consent. Participants will provide semen and blood samples for laboratory assessment of sperm quality and molecular characteristics before and after cryopreservation.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Male participants aged 18-39 years who provide semen and blood samples for laboratory assessment of sperm quality and molecular characteristics. Semen samples are divided into fresh, slow-frozen, and vitrified aliquots for comparative analysis.
Male participants aged 40-49 years who provide semen and blood samples for laboratory assessment of sperm quality and molecular characteristics. Semen samples are divided into fresh, slow-frozen, and vitrified aliquots for comparative analysis.
Male participants aged 50 years and older who provide semen and blood samples for laboratory assessment of sperm quality and molecular characteristics. Semen samples are divided into fresh, slow-frozen, and vitrified aliquots for comparative analysis.
Sperm DNA methylation profile
DNA methylation levels of a predefined nine-gene panel measured by pyrosequencing with duplicate measurements and compared between fresh, slow-frozen, and vitrified sperm samples.
Time frame: Baseline (study semen collection visit) and after thawing of cryopreserved semen samples, through study completion (up to 9 months).
Sperm concentration
Sperm concentration (million sperm/mL) measured using computer-assisted sperm analysis (CASA).
Time frame: Baseline (study semen collection visit) and after thawing of cryopreserved semen samples, through study completion (up to 9 months).
Total sperm motility
Percentage of motile sperm measured using CASA.
Time frame: Baseline (study semen collection visit) and after thawing of cryopreserved semen samples, through study completion (up to 9 months).
Progressive sperm motility
Percentage of progressively motile sperm measured using computer-assisted sperm analysis (CASA).
Time frame: Baseline (study semen collection visit) and after thawing of cryopreserved semen samples, through study completion (up to 9 months).
Normal sperm morphology
Percentage of sperm with normal morphology assessed by microscopic evaluation of stained slides according to World Health Organization (WHO) criteria.
Time frame: Baseline (study semen collection visit) and after thawing of cryopreserved semen samples, through study completion (up to 9 months).
Sperm DNA fragmentation
DNA fragmentation measured in fresh, slow-frozen, and vitrified sperm samples.
Time frame: Baseline (study semen collection visit) and after thawing of cryopreserved semen samples, through study completion (up to 9 months).
Sperm telomere length
Sperm telomere length measured in fresh, slow-frozen, and vitrified sperm samples.
Time frame: Baseline (study semen collection visit) and after thawing of cryopreserved semen samples, through study completion (up to 9 months).
Seminal plasma extracellular vesicle composition
Characterization of seminal plasma extracellular vesicle composition in fresh semen samples.
Time frame: Baseline (study semen collection visit).
Blood leukocyte telomere length
Blood cell telomere length measured to investigate its relationship with participant age and sperm molecular characteristics.
Time frame: Baseline (study blood collection visit).
Plan to share: Undecided
Started Jun 2026 (actual). Primary completion is estimated for Mar 2027, 9 months after the start.
Of 209 non-industry observational studies under Infertility, half reached primary completion within 39 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 100. This study's planned 9 months is below that.
Counting every sponsor, half of 242 studies reached it within 39 months; a quarter within 16 and three quarters within 100.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.